GLP-1 Agonists
GLP-1 receptor agonists and multi-receptor incretin molecules — the current frontier of research in type 2 diabetes, obesity, and cardiometabolic disease. Includes single agonists, dual agonists (GIP/GLP-1), and the first triple agonists (GLP-1/GIP/glucagon).
GLP-1 Agonists
Tirzepatide pen
from €209.00
Tirzepatide is a 39-amino-acid synthetic dual agonist of the GLP-1 and GIP receptors, developed by Eli Lilly and approved by the FDA in 2…
Retatrutide Pen
from €269.00
Retatrutide is a first-in-class synthetic triple agonist of the GLP-1, GIP, and glucagon receptors, developed by Eli Lilly as the next ev…
Mazdutide
from €119.00
Mazdutide (IBI362, LY3305677) is a synthetic dual agonist of the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor, orig…
Tirzepatide
from €69.00
Tirzepatide is a 39-amino-acid synthetic dual agonist of the GLP-1 and GIP receptors, developed by Eli Lilly and approved by the FDA in 2…
Retatrutide
from €129.00
Retatrutide is a first-in-class synthetic triple agonist of the GLP-1, GIP, and glucagon receptors, developed by Eli Lilly as the next ev…
💬 Комментарии